Sheryl Verbitski, PhD

Vaccine Clinic Manager at 365 Health
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Littleton, Colorado, United States, US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Wellness and Fitness Services
    • 1 - 100 Employee
    • Vaccine Clinic Manager
      • Dec 2021 - Present

      Develop and strengthen relationships with the Colorado Department of Public Health and Environment, Local Public Health Departments, and Community-Based Organizations to provide free and equitable access to Covid -19 and ACIP-recommended vaccines for underserved and marginalized communities in Colorado. Since February 2021, we have hosted over 650 mobile vaccine clinics to meet community members at trusted and easily accessed locations.

    • Vaccine Clinic and Testing Site Lead
      • Feb 2021 - Dec 2021

      365 Health (formally 9Health Fair) onsite lead for Covid-19 and influenza equity-based vaccination clinics and Covid-19 testing sites at community-based venues throughout Colorado.

    • United States
    • Higher Education
    • 700 & Above Employee
    • Adjunct Professor
      • Jan 2010 - May 2017

      ▪ Medical Microbiology, Spring 2017 (BL254) ▪ Microbiology Laboratory, Fall 2016 (BL419) ▪ Medical Microbiology Laboratory, Spring 2015, 2016 (BL255) ▪ Chemistry I Laboratory, Spring 2011 (CHEM 211) ▪ Introduction to Environmental Science Laboratory, Spring 2010 (ENVS 251) ▪ Medical Microbiology, Spring 2017 (BL254) ▪ Microbiology Laboratory, Fall 2016 (BL419) ▪ Medical Microbiology Laboratory, Spring 2015, 2016 (BL255) ▪ Chemistry I Laboratory, Spring 2011 (CHEM 211) ▪ Introduction to Environmental Science Laboratory, Spring 2010 (ENVS 251)

    • New Developments Manager
      • 2003 - 2009

      - Created a new department, which encompassed 4 financial divisions with ISO 17025 client accreditation. - Optimized ChromaDex’s first new rapid-screening assay (Bioluminex, Patent 800023746A) and brought it to market while working as the technical and product manager. - Awarded a $100,000 NSF phase I SBIR. - Managed all department’s grant and contract obligations, including a FDA grant to develop a rapid-screening assay (Bioluminex™) for complex mixtures, a BIRDF grant to jointly develop and promote a rapid-assay (FermaFact™ and ProBioFermFact™) for glycosylation profiling, and 3 NIH contracts for method development and compound isolation. - Key member of ChromaDex’s ISO 17025 audit team, which achieved the company’s first successful client accreditation. - Identify opportunities to leverage contracts and relationships such as a re-negotiation with a sub-contractor that resulted in a 37% company discount on their primary contracted service. - Promoted the department’s capabilities through sales and conference presentations. - Supported sales and marketing through technical support, client demonstrations, and training seminars. Show less

    • United States
    • Higher Education
    • 700 & Above Employee
    • Research Assistant
      • 1997 - 2003

      Primary research concentrated on the isolation, structure determination, and biological activity of marine natural products and focused on the following topics: The isolation, structure determination, and biological activity of a novel alkaloid perophoramidine from a Philippine ascidian, Perophora namei. (J. Org. Chem. 2002, 67, 7124-1726); The punaglandins, a class of chlorinated prostaglandins inhibition of ubiquitin isopeptidase activity. (J. Med. Chem. 2004, Apr 8;47(8):2062-70); The association between various actin disrupting compounds and the inhibition of AKT phosphorylation and induction of p53 accumulation. Biology - involved mammalian cell culture, growth inhibition and apoptosis assays, cell cycle analysis, immunochemistry, isopeptidase assays (in vivo and in vitro), and immunocytochemistry. Some experience with bacterial transfection and protein isolation (ubiquitin). Chemistry - involved extraction, isolation, and structure determination of natural products: primarily used chromatography (TLC, HPLC, flash, and gravity), crystallization, synthesis, 1 and 2D NMR (1H, 13C, 15N), MS (FAB, ES, EI, CI), UV, IR, and CD. Show less

    • United States
    • Construction
    • 1 - 100 Employee
    • Research and Development Chemist
      • Jan 1996 - Aug 1997

      - Contributed significantly to a 1 year project to reformulate 80% of Duron’s interior-latex paints. - Successfully met performance goals while working for 1 year with no direct supervisor and limited formal coatings training. - Implemented an IR and microscope facility to investigate customer complaints. - Contributed significantly to a 1 year project to reformulate 80% of Duron’s interior-latex paints. - Successfully met performance goals while working for 1 year with no direct supervisor and limited formal coatings training. - Implemented an IR and microscope facility to investigate customer complaints.

Education

  • University of Utah
    Doctor of Philosophy (Ph.D.), Medicinal Chemistry
    1997 - 2003
  • University of Utah
    Ph.D., Medicinal and Pharmaceutical Chemistry
    1997 - 2003
  • University of Maryland College Park
    Bachelor's Degree, Chemistry
    1992 - 1995
  • University of Maryland
    B.S., Chemistry
    1995 -

Community

You need to have a working account to view this content. Click here to join now